NRXP (STOCKS)
NRX Pharmaceuticals, Inc. Common Stock
$2.710000
+0.120000 (+4.63%)
Prev close: $2.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jonathan C. Javitt
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $117.12M
- Employees
- 29
- P/E (TTM)
- -3.52
- P/B (TTM)
- -657.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.44 | $0.07 | -0.5053 | -773.81% |
|
Mar 2026 (Q1)
|
$-0.04 | $0.29 | -0.3332 | -113.64% |
|
Dec 2025 (Q4)
|
$-0.01 | $0.00 | -0.0094 | -361.54% |
|
Sep 2025 (Q3)
|
$-0.50 | $-0.09 | -0.4133 | -476.70% |